Findings for the period from 22 June 2020 to 28 June 2020.

Results of FABOLUS-FASTER trial support parenteral drugs for rapid platelet inhibition.

Heart failure is less common than other cardiovascular or renal comorbidities but more often fatal.

Our weekly summary of practical COVID-19 developments across Europe

Authors lay blame on systemic illness following on severe infection.

The latest stories you need to know.

Obesity and injected drug use is associated with pulmonary arterial enlargement

New evidence that romosozumab may lead to excess cardiovascular complications.

Both are protective, but head-to-head studies have been lacking.

The latest UK coronavirus stories you need to know.

Findings from a retrospective comparative study.

Indirect comparison finds lowest MACE and CV death with injected and oral once-weekly formulations.

High index of suspicion and long-term follow-up are both warranted.

Increased risk seen especially in men.